Early-Stage Bladder Cancer Surveillance Does Not Improve Survival If High-Risk Patients Are Permitted to Progress to Muscle Invasion

Urology

Volumn 69, Issue 6, 2007, Pages 1068-1072

  Lee, Cheryl T ^a   Dunn, Rodney L ^a   Ingold, Collette ^a   Montie, James E ^a   Wood Jr , David P ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER MUSCLE; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CYSTECTOMY; DISEASE COURSE; DISEASE SPECIFIC SURVIVAL; EARLY CANCER; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; COHORT STUDIES; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 34250001722     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.02.064     Document Type: Article

References (19)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Zieger K., Wolf H., Olsen P.R., et al. Long-term survival of patients with bladder tumours: the significance of risk factors. Br J Urol 82 (1998) 667-672
3. Holmang S., Hedelin H., Anderstrom C., et al. Recurrence and progression in low grade papillary urothelial tumors. J Urol 162 (1999) 702-707
4. Cookson M.S., Herr H.W., Zhang Z.F., et al. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158 (1997) 62-67
5. Reading J., Hall R.R., and Parmar M.K. The application of a prognostic factor analysis for Ta-T1 bladder cancer in routine urological practice. Br J Urol 75 (1995) 604-607
6. Jichlinski P., Guillou L., Karlsen S.J., et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer-a multicenter study. J Urol 170 (2003) 226-229
7. Lotan Y., and Roehrborn C.G. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61 (2003) 109-118
8. Tawfiek E.R., and Bagley D.H. Upper-tract transitional cell carcinoma. Urology 50 (1997) 321-329
9. Parmar M.K., Freedman L.S., Hargreave T.B., et al. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol 142 (1989) 284-288
10. Schrier B.P., Hollander M.P., van Rhijn B.W., et al. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 45 (2004) 292-296
11. Miladi M., Peyromaure M., Zerbib M., et al. The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol 43 (2003) 241-245
12. Marshall F.F. Surgery of the bladder. In: Walsh P.C., Retik A.B., Vaughan Jr. E.D., et al. (Eds). Campbell's Urology (1998), WB Saunders, Philadelphia 3274-3297
13. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
14. Esrig D., Freeman J.A., Stein J.P., et al. Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder. Semin Urol Oncol 15 (1997) 154-160
15. Hautmann R.E., Gschwend J.E., de Petriconi R.C., et al. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 176 (2006) 486-492
16. American Joint Committe on Cancer. Urinary bladder. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. (2002), Springer-Verlag, New York 367-373
17. Donat S.M. Evaluation and follow-up strategies for superficial bladder cancer. Urol Clin North Am 30 (2003) 765-776
18. Bochner B.H., Montie J.E., and Lee C.T. Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer. Urol Clin North Am 30 (2003) 777-789
19. Epstein J.I., Amin M.B., Reuter V.R., et al., Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22 (1998) 1435-1448